Skip to main content

Duration of Follow Up for New Molecular Entities Approved in 2007: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
new molecular entities (NMEs)
Description

The purpose of this analysis was to characterize incident and prevalent users of new molecular entities (NMEs) approved in 2007 and to characterize procedure codes for NMEs approved in 2007. We distributed this request to 16 Sentinel Data Partners on August 24, 2017.

This analysis contains three reports:

  • Report 1: This report characterizes incident users of NMEs approved in 2007. The study period includes data from 2007 to 2016.
  • Report 2: This report characterizes prevalent users of NMEs approved in 2007. The study period includes data from 2007 to 2016. 
  • Report 3: This report characterizes procedure codes for NMEs approved in 2007. The study period includes data from 2010 to 2016.

 

Deliverables (3)
Sentinel Summary Table Report: Duration of Follow Up for New Molecular Entities Approved in 2007: A Descriptive Analysis, Report 1 Sentinel Summary Table Report: Duration of Follow Up for New Molecular Entities Approved in 2007: A Descriptive Analysis, Report 2 Sentinel Summary Table Report: Duration of Follow Up for New Molecular Entities Approved in 2007: A Descriptive Analysis, Report 3
Additional Details
FDA Center
CDER
Time Period
2007 - 2016; 2010 - 2016
Analysis Type
Summary Table
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: New Molecular Entities (NMEs) & Utilization Characterization